Decision of the National Standardization Institute No. 382 dated 09.10.2014

This standard establishes comprehensive requirements and guidelines for the evaluation of the effectiveness of disinfection agents and antiseptics used in the medical field. It specifies the quantitative suspension tests and field trials necessary to assess the bactericidal, tuberculocidal, fungicidal, virucidal, and sporicidal properties of chemical products. The document outlines precise methodologies for determining reduction ratios under controlled laboratory conditions, ensuring consistent and reliable data across different testing environments. It covers various test strains relevant to clinical settings and defines specific criteria for passing the assessment. The procedures address both liquid and surface applications, providing a framework for manufacturers and regulatory bodies to verify product claims. This document is designed to harmonize testing protocols to facilitate international trade and enhance patient safety through validated infection control measures.